Hopes for the Johnson & Johnson (J&J) Mosaico vaccine – the one HIV vaccine candidate in late-stage (Section 3) medical trials – had been dashed with producer Janssen Prescribed drugs’ latest announcement that the vaccine lacked efficacy in stopping HIV an infection. Within the wake of this announcement, prime South …
Read More »Africa: HIV Vaccine Research Set to Change Focus in Wake of Mosaico Disappointment read full article at worldnews365.me
